SCHEMBL8000126

SCHEMBL8000126

COCC/C=C/c1cc(C)ccc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.44
L3MBTL4 Q8NA19 1/20 0.41
L3MBTL3 Q96JM7 1/20 0.41
ALDH1A1 P00352 5/20 0.41
CYP3A4 P08684 2/20 0.41
HPGD P15428 6/20 0.40
MAPT P10636 5/20 0.40
L3MBTL1 Q9Y468 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP1A1 P04798 2/20 0.39
CYP1B1 Q16678 2/20 0.39
CYP1A2 P05177 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8001694 0.91 L3MBTL4 (0.42) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7990539 0.91 L3MBTL4 (0.42) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7991255 0.89 L3MBTL4 (0.41) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7990258 0.83 ACHE (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7998464 0.83 ACHE (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL2931695 0.83 MAPT (0.48) ALDH1A1CYP3A4MAPTL3MBTL1MEN1
SCHEMBL2931694 0.83 MAPT (0.48) ALDH1A1CYP3A4MAPTL3MBTL1MEN1
SCHEMBL7998889 0.82 L3MBTL4 (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7989766 0.82 L3MBTL4 (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4
SCHEMBL7989707 0.80 ACHE (0.38) ACHEL3MBTL4L3MBTL3ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117594-A1 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-09-24 WO disclosed